Top Medical Stocks to Monitor Ahead of Q2 Earnings: ABT, JNJ, NVS

Avatar photo

Key Earnings Reports This Week: Major healthcare companies are set to report their Q2 results. Johnson & Johnson (JNJ) is scheduled to release its earnings on July 16, forecasting a 5% drop in EPS to $2.66, while its dividend yield stands at 3.32%. Novartis (NVS) will report on July 17, with anticipated revenue growth of 9% to $14.04 billion and EPS rising 21% to $2.38. Abbott Laboratories (ABT) is also reporting on July 17, expecting a 9% increase in EPS to $1.25 and sales growth of nearly 7% to $11.07 billion.

Market Context: The S&P 500 and Nasdaq reached new highs as of this past Tuesday, despite inflation concerns indicated by June’s CPI report. Investors are advised to consider defensive positions in the healthcare sector amid potential market volatility.

The free Daily Market Overview 250k traders and investors are reading

Read Now